Cheol Young Maeng
16Patents
4h-index
39Co-inventors
56Inventor score
Filing activity: Mar 22, 2003 → Jun 1, 2021
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US9403761B2 | Aminocarbonylcarbamate compounds | Chemistry; Metallurgy | 25 | Active |
| US8716309B2 | Pharmaceutical composition comprising pyridone derivatives | Human Necessities | 7 | Active |
| US9833432B2 | Aminocarbonylcarbamate compounds | Chemistry; Metallurgy | 6 | Active |
| US10314808B2 | Aminocarbonylcarbamate compounds | Chemistry; Metallurgy | 5 | Active |
| US8952165B2 | Pharmaceutical composition comprising pyridone derivatives | Chemistry; Metallurgy | 3 | Active |
| US9271976B2 | Pharmaceutical composition comprising pyridone derivatives | Chemistry; Metallurgy | 2 | Active |
| US10888542B2 | Aminocarbonylcarbamate compounds | Chemistry; Metallurgy | 2 | Active |
| US8420353B2 | Humanized antibody and process for preparing same | Chemistry; Metallurgy | 2 | Expired |
| US10485781B2 | Aminocarbonylcarbamate compounds | Chemistry; Metallurgy | 1 | Active |
| US9745310B2 | Imidazopyrimidine and imidazotriazine derivative, and pharmaceutical composition comprising the same | Human Necessities | 1 | Active |
| US10100057B2 | Imidazopyrimidine and imidazotriazine derivative, and pharmaceutical composition comprising the same | Human Necessities | 1 | Active |
| US9987259B2 | Pharmaceutical composition comprising pyridone derivatives | Chemistry; Metallurgy | 1 | Active |
| US12037338B2 | Imidazopyrimidine and imidazotriazine derivative, and pharmaceutical composition comprising the same | Human Necessities | 0 | Active |
| US8039634B2 | Oxazole hydroxamic acid derivatives and use thereof | Chemistry; Metallurgy | 0 | Active |
| US11046702B2 | Imidazopyrimidine and imidazotriazine derivative, and pharmaceutical composition comprising the same | Human Necessities | 0 | Active |
| US10456385B2 | Pharmaceutical composition comprising pyridone derivatives | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.